Apolipoprotein E (APOE)

Apo-E; AD2; Apoprotein; Alzheimer Disease 2(E4-Associated,Late Onset

SPN	W108
HGNC	613
MGI	88057
PubMed	11701639
RGD	2138
UniProt	P02649
Wiki	APOE

Apolipoprotein E, a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells. ApoE is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. Apolipoprotein E has many functions in the body. When it is synthesized by the liver as part of VLDL it functions in the transport of triglycerides to the liver tissue. It is also incorporated into HDL (as HDL-E) and functions in cholesterol distribution among cells. It is also incorporated into intestinally synthesized cholymicrons and transports dietary triglycerides and cholesterol. It is involved in lipid metabolism by mediating the receptor binding of apo-E lipoproteins to the LDL receptor. Receptor binding begins the cellular uptake of lipoproteins to be used in intracellular cholesterol metabolism.

Reference

"Synthesis, intracellular processing, and signal peptide of human apolipoprotein E."
J. Biol. Chem. 259:5495-5499(1984) [PubMed] [Europe PMC] [Abstract]

"Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant."
J. Biol. Chem. 259:6498-6504(1984) [PubMed] [Europe PMC] [Abstract]

"Nucleotide sequence and structure of the human apolipoprotein E gene."
Proc. Natl. Acad. Sci. U.S.A. 82:3445-3449(1985) [PubMed] [Europe PMC] [Abstract]

"Genotyping and sequence analysis of apolipoprotein E isoforms."
Genomics 3:373-379(1988) [PubMed] [Europe PMC] [Abstract]

"Sequencing of 42kb of the APO E-C2 gene cluster reveals a new gene: PEREC1."
DNA Seq. 9:89-100(1998) [PubMed] [Europe PMC] [Abstract]

"Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene."
Genome Res. 10:1532-1545(2000) [PubMed] [Europe PMC] [Abstract]

"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]

"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]

"Identification and DNA sequence of a human apolipoprotein E cDNA clone."
J. Biol. Chem. 257:14639-14641(1982) [PubMed] [Europe PMC] [Abstract]

Erratum
J. Biol. Chem. 258:11422-11422(1983)

"Human apolipoprotein E. The complete amino acid sequence."
J. Biol. Chem. 257:4171-4178(1982) [PubMed] [Europe PMC] [Abstract]

"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology."
Science 240:622-630(1988) [PubMed] [Europe PMC] [Abstract]

"Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains."
Biochem. Biophys. Res. Commun. 134:783-789(1986) [PubMed] [Europe PMC] [Abstract]

"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families."
Science 261:921-923(1993) [PubMed] [Europe PMC] [Abstract]

"Glycation of apolipoprotein E impairs its binding to heparin: identification of the major glycation site."
Biochim. Biophys. Acta 1454:296-308(1999) [PubMed] [Europe PMC] [Abstract]

"Enrichment of glycopeptides for glycan structure and attachment site identification."
Nat. Methods 6:809-811(2009) [PubMed] [Europe PMC] [Abstract]

"Initial characterization of the human central proteome."
BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]

"Resveratrol-induced changes of the human adipocyte secretion profile."
J. Proteome Res. 11:4733-4743(2012) [PubMed] [Europe PMC] [Abstract]

"LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins."
J. Proteome Res. 12:573-584(2013) [PubMed] [Europe PMC] [Abstract]

"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."
J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]

"Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E."
Science 252:1817-1822(1991) [PubMed] [Europe PMC] [Abstract]

"Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia."
Nat. Struct. Biol. 3:718-722(1996) [PubMed] [Europe PMC] [Abstract]

"Conformational flexibility in the apolipoprotein E amino-terminal domain structure determined from three new crystal forms: implications for lipid binding."
Protein Sci. 9:886-897(2000) [PubMed] [Europe PMC] [Abstract]

"Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels."
Hum. Mutat. 4:178-194(1994) [PubMed] [Europe PMC] [Abstract]

"Molecular cloning of a human apolipoprotein E variant: E5 (Glu-3-->Lys)."
J. Biochem. 105:491-493(1989) [PubMed] [Europe PMC] [Abstract]

"Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121-127."
J. Biol. Chem. 264:21205-21210(1989) [PubMed] [Europe PMC] [Abstract]

"Apolipoprotein E-4 Philadelphia (Glu-13-->Lys,Arg-145-->Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia."
J. Biol. Chem. 266:10479-10484(1991) [PubMed] [Europe PMC] [Abstract]

"Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia."
Am. J. Hum. Genet. 52:937-946(1993) [PubMed] [Europe PMC] [Abstract]

"Common and rare genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA."
Clin. Chem. 40:24-29(1994) [PubMed] [Europe PMC] [Abstract]

"Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy."
J. Am. Soc. Nephrol. 8:820-823(1997) [PubMed] [Europe PMC] [Abstract]

"Apolipoprotein E R112; R251G: a carboxy-terminal variant found in patients with hyperlipidemia and coronary heart disease."
Mutat. Res. 382:57-65(1997) [PubMed] [Europe PMC] [Abstract]

"A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy."
Kidney Int. 56:421-427(1999) [PubMed] [Europe PMC] [Abstract]

"Familial splenomegaly: macrophage hypercatabolism of lipoproteins associated with apolipoprotein E mutation [apolipoprotein E (delta149 Leu)]."
J. Clin. Endocrinol. Metab. 85:4354-4358(2000) [PubMed] [Europe PMC] [Abstract]

"Apolipoprotein E3Basel: new insights into a highly conserved protein region."
Eur. J. Clin. Invest. 33:677-685(2003) [PubMed] [Europe PMC] [Abstract]

"Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors."
Hum. Mol. Genet. 12:2733-2743(2003) [PubMed] [Europe PMC] [Abstract]

"Variable expressivity of the clinical and biochemical phenotype associated with the apolipoprotein E p.Leu149del mutation."
Eur. J. Hum. Genet. 13:1186-1191(2005) [PubMed] [Europe PMC] [Abstract]

"APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy."
N. Engl. J. Med. 357:2522-2524(2007) [PubMed] [Europe PMC] [Abstract]

"Quantitative detection of single amino acid polymorphisms by targeted proteomics."
J. Mol. Cell Biol. 3:309-315(2011) [PubMed] [Europe PMC] [Abstract]

"Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia."
Atherosclerosis 222:449-455(2012) [PubMed] [Europe PMC] [Abstract]

"Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation."
Hum. Mutat. 34:83-87(2013) [PubMed] [Europe PMC] [Abstract]